Pelvalon Announces Pivotal Trial Results

Pelvalon made its clinical debut at AUGS today with some truly amazing results.  The team has worked incredibly hard over the past four years to developed a new treatment paradigm for one of the most debilitating conditions, fecal incontinence.  The PI of the study summarized it best: “This trial heralds a new era of treatment opportunity for women with bowel control problems.”  Hats off to everyone at Pelvalon!